Trump appointees at the Centers for Disease Control and Prevention spoke to The New York Times regarding turmoil at the agency. Kyle McGowan, a former chief of staff at the CDC, and his deputy, Amanda Campbell, were among those to go public. (The New York Times)
The Department of Health and Human Services grants another $4.5 billion to healthcare providers fighting the COVID-19 pandemic. The emergency funding follows an earlier $20 billion earmarked by HHS for hospitals and medical providers struggling with costs. (Reuters)
The EU may approve the Pfizer/BioNTech COVID-19 vaccine before Christmas. Following approvals in the US and UK, the European Medicines Agency has moved up the meeting of an expert panel from December 29 to December 21. (ABC News)
Gilead has shelved a much-touted rheumatoid arthritis program. The suspension of the program follows the company’s struggles securing FDA approval for Jyseleca. (EndpointsNews)
The Trump administration may send out $200 drug prescription cards to Medicare recipients by January 1. The campaign promise by Trump had been delayed following opposition from both Democrats and members of his administration. (Bloomberg)
